Statistics
Publications
18
Citations
1.2K
H-Index
15
Active since
1991
Rikio Suzuki is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.
Publications per year
1991–2023
18
18
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
J. Minami, Rikio Suzuki, Ralph Mazitschek et al. · Leukemia · 2013 · 160 citations
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma
Francesca Cottini, Teru Hideshima, Rikio Suzuki et al. · Cancer Discovery · 2015 · 116 citations · Full text
The KDM3A–KLF2–IRF4 axis maintains myeloma cell survival
Hiroto Ohguchi, Teru Hideshima, Manoj Bhasin et al. · Nature Communications · 2016 · 109 citations · Full text
Medicine, Cell Biology, Oncology +15
Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma
Shohei Kikuchi, Rikio Suzuki, Hiroto Ohguchi et al. · Leukemia · 2015 · 92 citations
1–5 of 18